New Zealand markets closed

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0100+0.0285 (+2.90%)
At close: 04:00PM EDT
1.0400 +0.03 (+2.97%)
Pre-market: 04:15AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 142.17M
Enterprise value 265.05M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.01
Price/book (mrq)12.60
Enterprise value/revenue 2.25
Enterprise value/EBITDA -1.90

Trading information

Stock price history

Beta (5Y monthly) 0.98
52-week change 3-77.40%
S&P500 52-week change 311.79%
52-week high 34.6600
52-week low 30.9300
50-day moving average 31.4366
200-day moving average 31.9261

Share statistics

Avg vol (3-month) 31.87M
Avg vol (10-day) 31.78M
Shares outstanding 5140.76M
Implied shares outstanding 6140.76M
Float 8104.9M
% held by insiders 10.78%
% held by institutions 192.05%
Shares short (14 Sept 2023) 425.75M
Short ratio (14 Sept 2023) 416.24
Short % of float (14 Sept 2023) 421.28%
Short % of shares outstanding (14 Sept 2023) 418.29%
Shares short (prior month 14 Aug 2023) 427.76M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 312 Jan 2014

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Jun 2023


Profit margin -115.80%
Operating margin (ttm)-112.16%

Management effectiveness

Return on assets (ttm)-37.15%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)117.96M
Revenue per share (ttm)1.00
Quarterly revenue growth (yoy)15.00%
Gross profit (ttm)-50.51M
EBITDA -129.35M
Net income avi to common (ttm)-136.6M
Diluted EPS (ttm)-1.1500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)33.24M
Total cash per share (mrq)0.24
Total debt (mrq)156.12M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.91
Book value per share (mrq)-0.33

Cash flow statement

Operating cash flow (ttm)-126.67M
Levered free cash flow (ttm)-82.65M